The efficacy and safety of first‑line anti‑PD‑1/PD‑L1 immunotherapy for gastric esophageal cancer: A systematic review and meta‑analysis of phase III randomized controlled trials-Reference-Cited by-同舟云学术

The efficacy and safety of first‑line anti‑PD‑1/PD‑L1 immunotherapy for gastric esophageal cancer: A systematic review and meta‑analysis of phase III randomized controlled trials

Published:2023-03-28 Issue:5 Volume:25 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Duan Xiaoyang¹,Du Huazhen²,Qi Ran³,Yuan Meng⁴,Shi Jian¹

Affiliation:

1. Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China

2. Department of Emergency, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China

3. Department of Pharmacy, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China

4. Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka 807‑8555, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Reference32 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Utilization and efficacy of palliative chemotherapy for locally advanced or metastatic gastroesophageal carcinoma;Baumgartner;Anticancer Res,2020

3. Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer;van den Ende;Best Pract Res Clin Gastroenterol,2018

4. The anti-PD-1/PD-L1 immunotherapy for gastric esophageal cancer: A systematic review and meta-analysis and literature review;Chen;Cancer Control,2021

5. Anti-PD-1 and anti-CTLA-4 therapies in cancer: Mechanisms of action, efficacy, and limitations;Seidel;Front Oncol,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indole-3-carbinol inhibits immune evasion in esophageal carcinoma by regulating CES1;2024-07-19